These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 22277140)

  • 1. Carvedilol-lisinopril combination therapy and endothelial function in obese individuals with hypertension.
    Kelly AS; Gonzalez-Campoy JM; Rudser KD; Katz H; Metzig AM; Thalin M; Bank AJ
    J Clin Hypertens (Greenwich); 2012 Feb; 14(2):85-91. PubMed ID: 22277140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity and hypertension: a common coexistence.
    Mende CW
    J Clin Hypertens (Greenwich); 2012 Mar; 14(3):137-8. PubMed ID: 22372771
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of combining extended-release carvedilol and lisinopril in hypertension: results of the COSMOS study.
    Bakris GL; Iyengar M; Lukas MA; Ordronneau P; Weber MA
    J Clin Hypertens (Greenwich); 2010 Sep; 12(9):678-86. PubMed ID: 20883227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in mean and variability of heart rate and ambulatory rate-pressure product when valsartan or carvedilol is added to lisinopril.
    Izzo JL; Yedlapati SH; Faheem SM; Younus U; Osmond PJ
    J Am Soc Hypertens; 2012; 6(6):399-404. PubMed ID: 23107894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of combining extended-release carvedilol and lisinopril in hypertension: results of the COSMOS study.
    Flack JM
    J Clin Hypertens (Greenwich); 2010 Sep; 12(9):664-5. PubMed ID: 20928961
    [No Abstract]   [Full Text] [Related]  

  • 6. Hemodynamic and central blood pressure differences between carvedilol and valsartan added to lisinopril at rest and during exercise stress.
    Izzo JL; Rajpal M; Karan S; Srikakarlapudi S; Osmond PJ
    J Am Soc Hypertens; 2012; 6(2):117-23. PubMed ID: 22264722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of carvedilol and nebivolol on oxidative stress-related parameters and endothelial function in patients with essential hypertension.
    Zepeda RJ; Castillo R; Rodrigo R; Prieto JC; Aramburu I; Brugere S; Galdames K; Noriega V; Miranda HF
    Basic Clin Pharmacol Toxicol; 2012 Nov; 111(5):309-16. PubMed ID: 22703478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of carvedilol, lisinopril and their combination on vascular and cardiac health in patients with borderline blood pressure: the DETECT Study.
    Saul SM; Duprez DA; Zhong W; Grandits GA; Cohn JN
    J Hum Hypertens; 2013 Jun; 27(6):362-7. PubMed ID: 23190794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-oxidative properties of beta-blockers and angiotensin-converting enzyme inhibitors in congestive heart failure.
    Chin BS; Langford NJ; Nuttall SL; Gibbs CR; Blann AD; Lip GY
    Eur J Heart Fail; 2003 Mar; 5(2):171-4. PubMed ID: 12644008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of perindopril and carvedilol on endothelium-dependent vascular functions in patients with diabetes and hypertension.
    Giugliano D; Marfella R; Acampora R; Giunta R; Coppola L; D'Onofrio F
    Diabetes Care; 1998 Apr; 21(4):631-6. PubMed ID: 9571355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of carvedilol versus metoprolol on endothelial function and oxidative stress in patients with type 2 diabetes mellitus.
    Bank AJ; Kelly AS; Thelen AM; Kaiser DR; Gonzalez-Campoy JM
    Am J Hypertens; 2007 Jul; 20(7):777-83. PubMed ID: 17586413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
    Wald DS; Law M; Mills S; Bestwick JP; Morris JK; Wald NJ
    Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artist® tablets (carvedilol) for hypertensive patients in Japan: results of a drug use survey.
    Mori Y; Nishikawa Y; Iizuka T; Zenimura N; Matsumoto T; Hiramatsu K; Komiya M
    Drugs R D; 2011; 11(2):171-90. PubMed ID: 21679007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effects of carvedilol as a concomitant therapy to angiotensin-converting enzyme inhibitor in patients with ischemic left ventricular systolic dysfunction.
    Gandhi PS; Goyal RK; Jain AR; Mallya BS; Gupta VM; Shah DS; Trivedi BR; Shastri NA; Mehta CB; Jain KA; Bhavasar NS; Shah UJ
    Can J Physiol Pharmacol; 2007 Feb; 85(2):193-9. PubMed ID: 17487260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The benefits of early combination treatment of carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction. The carvedilol and ACE-inhibitor remodelling mild heart failure evaluation trial (CARMEN).
    Remme WJ; Riegger G; Hildebrandt P; Komajda M; Jaarsma W; Bobbio M; Soler-Soler J; Scherhag A; Lutiger B; Rydén L
    Cardiovasc Drugs Ther; 2004 Jan; 18(1):57-66. PubMed ID: 15115904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a quercetin-rich onion skin extract on 24 h ambulatory blood pressure and endothelial function in overweight-to-obese patients with (pre-)hypertension: a randomised double-blinded placebo-controlled cross-over trial.
    Brüll V; Burak C; Stoffel-Wagner B; Wolffram S; Nickenig G; Müller C; Langguth P; Alteheld B; Fimmers R; Naaf S; Zimmermann BF; Stehle P; Egert S
    Br J Nutr; 2015 Oct; 114(8):1263-77. PubMed ID: 26328470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carvedilol and atenolol once daily in the treatment of hypertension.
    Luurila OJ; Härkönen R; Hilden M; Icen R; Kohvakka A; Linna M; Sillanpää J; Vänskä O; Lukkala K
    J Hypertens Suppl; 1989 Dec; 7(6):S264-5. PubMed ID: 2576666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of beta blockade (carvedilol or metoprolol) on activation of the renin-angiotensin-aldosterone system and natriuretic peptides in chronic heart failure.
    Fung JW; Yu CM; Yip G; Chan S; Yandle TG; Richards AM; Nicholls MG; Sanderson JE
    Am J Cardiol; 2003 Aug; 92(4):406-10. PubMed ID: 12914870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of carvedilol on left ventricular function and oxidative stress in infants and children with idiopathic dilated cardiomyopathy: a 12-month, two-center, open-label study.
    Bajcetic M; Kokic Nikolic A; Djukic M; Kosutic J; Mitrovic J; Mijalkovic D; Jovanovic I; Simeunovic S; Spasic MB; Samardzic R
    Clin Ther; 2008 Apr; 30(4):702-14. PubMed ID: 18498919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure effects of combined β-blocker and angiotensin-converting enzyme inhibitor therapy compared with the individual agents: a placebo-controlled study with nebivolol and lisinopril.
    Weber MA; Basile J; Stapff M; Khan B; Zhou D
    J Clin Hypertens (Greenwich); 2012 Sep; 14(9):588-92. PubMed ID: 22947356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.